Previous Close | 2.72 |
1-Year Change | -80.57% |
6-Months Change | -74.95% |
3-Months Change | -46.56% |
Moving Avg (50d) | 4.6978 |
Moving Avg (200d) | 9.564 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 59.0M |
Beta (3-Years) | 1.94 |
Revenue Growth (ttm) | 59% |
Net Profit Margin (ttm) | -141.9% |
Return On Assets (ttm) | -95.46% |
EPS (ttm) | -137.98 |
PE Ratio (ttm) | -0.02 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |